Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Erstveröffentlichung
2018Authors
Lawlor, Brian
Segurado, Ricardo
Kennelly, Sean
Rikkert, Marcel G. M. Olde
Howard, Robert
Wissenschaftlicher Artikel
Published in
PLoS Medicine ; 15 (2018), 9. - Art.-Nr. e1002660. - ISSN 1549-1676
Link to publication
https://dx.doi.org/10.1371/journal.pmed.1002660Institutions
Bezirkskrankenhaus GünzburgEU Project uulm
NILVAD / A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease / EC / FP7 / 279093